Cargando…
Role of inflammatory indices in management of hepatocellular carcinoma—neutrophil to lymphocyte ratio
Autor principal: | Shelat, Vishal G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475436/ https://www.ncbi.nlm.nih.gov/pubmed/32953712 http://dx.doi.org/10.21037/atm-2020-90 |
Ejemplares similares
-
The role of platelet-lymphocyte ratio in hepatocellular carcinoma: a valuable prognostic marker
por: Chan, Kai Siang, et al.
Publicado: (2022) -
Preoperative Neutrophil-to-Lymphocyte Ratio Plus Platelet-to-Lymphocyte Ratio Predicts the Outcomes after Curative Resection for Hepatocellular Carcinoma
por: Kabir, T., et al.
Publicado: (2019) -
Neutrophil-to-lymphocyte ratio as a prognostic biomarker in hepatocellular carcinoma after transarterial chemoembolization
por: Jeong, Soung Won
Publicado: (2020) -
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Patients with COVID-19
por: Piovani, Daniele, et al.
Publicado: (2022) -
Reassessing the role of the neutrophil-to-lymphocyte ratio in chronic kidney disease patients
por: Lee, Yu Ho
Publicado: (2023)